Academic Bibliography

Search 200 years of publications by Ghent University researchers.

prof. dr. Pieter Van Vlierberghe

Faculty of Medicine and Health Sciences > Department of Biomolecular Medicine

Work address: C. Heymanslaan 10, ingang 38 (MRB2)
9000 Gent
Email: Pieter.VanVlierberghe@UGent.be
ORCID iD: 0000-0001-9063-7205

Show Sort by

Add to list
Functional mapping of PHF6 complexes in chromatin remodeling, replication dynamics and DNA repair

Silvia Alvarez, Ana da Silva Almeida, Robert Albero, Mayukh Biswas, Angelica Barreto-Galvez, Thomas S. Gunning, Anam Shaikh, Tomas Aparicio, Agnieszka Anya Wendorff, Erich Piovan, et al.

(2022) BLOOD.
Add to list
ETV6-NCOA2 fusion induces T/myeloid mixed-phenotype leukemia through transformation of nonthymic hematopoietic progenitor cells

Hila Fishman, Shreyas Madiwale, Ifat Geron, Vase Bari, Wouter Van Loocke (UGent) , Yael Kirschenbaum, Itamar Ganmore, Eitan Kugler, Avigail Rein-Gil, Gilgi Friedlander, et al.

(2022) BLOOD. 139(3). p.399-412
Add to list
Myb drives B-cell neoplasms and myeloid malignancies in vivo

Tim Pieters (UGent) , André Pedro Pinto De Almeida (UGent) , Sara T'Sas (UGent) , Kelly Lemeire (UGent) , Tino Hochepied (UGent) , Geert Berx (UGent) , Alex Kentsis, Steven Goossens (UGent) and Pieter Van Vlierberghe (UGent)

(2022) BLOOD ADVANCES.
Add to list
- Journal Article
- A1
- open access
Novel insights on the use of L-asparaginase as an efficient and safe anti-cancer therapy

Maaike Van Trimpont (UGent) , Evelien Peeters (UGent) , Yanti De Visser (UGent) , Amanda M. Schalk, Veerle Mondelaers (UGent) , Barbara De Moerloose (UGent) , Arnon Lavie, Tim Lammens (UGent) , Steven Goossens (UGent) and Pieter Van Vlierberghe (UGent)

(2022) CANCERS. 14(4).
Add to list
Direct and indirect anti-leukemic properties of Activity-on-Target interferons for the treatment of T-cell acute lymphoblastic leukemia

Steven Goossens (UGent) , Anje Cauwels (UGent) , Tim Pieters (UGent) , Renate De Smedt (UGent) , Sara T'Sas (UGent) , André Pedro Pinto De Almeida (UGent) , Willem Daneels (UGent) , Pieter Van Vlierberghe (UGent) and Jan Tavernier (UGent)

(2022) HAEMATOLOGICA.
Add to list
SOX11 functions as an oncogene in Lmo2-driven T-cell lymphoblastic leukemia (T-ALL)

André Pedro Pinto De Almeida (UGent) , Tim Pieters (UGent) , Sara T'Sas (UGent) , Steven Goossens (UGent) and Pieter Van Vlierberghe (UGent)

(2021) BLOOD. In Blood 138(Supplement 1). p.1136-1136
Add to list
- Journal Article
- A1
- open access
Unlike its paralog LEDGF/p75, HRP-2 is dispensable for MLL-R leukemogenesis but important for leukemic cell survival

Siska Van Belle, Sara El Ashkar, Kateřina Čermáková, Filip Matthijssens (UGent) , Steven Goossens (UGent) , Alessandro Canella, Courtney H. Hodges, Frauke Christ, Jan De Rijck, Pieter Van Vlierberghe (UGent) , et al.

(2021) CELLS. 10(1).
Add to list
- Journal Article
- A1
- open access
Phosphocatalytic kinome activity profiling of apoptotic and ferroptotic agents in multiple myeloma cells

Emilie Logie, Claudina Perez Novo, Amber Driesen, Pieter Van Vlierberghe (UGent) and Wim Vanden Berghe

(2021) INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 22(23).
Add to list
T-ALL can evolve to oncogene independence

Hesham Abdulla, Anh Vo, Benjamin J. Shields, Tenae J. Davies, Jacob T. Jackson, Raed Alserihi, Elizabeth M. Viney, Tin Wong, Feng Yan, Nicholas C. Wong, et al.

(2021) LEUKEMIA. 35(8). p.2205-2219
Add to list
- Journal Article
- A1
- open access
Alternative glycosylation controls endoplasmic reticulum dynamics and tubular extension in mammalian cells

Despoina Kerselidou, Bushra Saeed Dohai, David R. Nelson, Sarah Daakour, Nicolas De Cock, Zahra Al Oula Hassoun, Dae-Kyum Kim, Julien Olivet, Diana C. El Assal, Ashish Jaiswal, et al.

(2021) SCIENCE ADVANCES. 7(19).

1
2
3
4
…
19
20

Next →